Sugi Predict

Sugi Predict / Compounds / SCHEMBL10698758

SCHEMBL10698758

SCHEMBL10698758

Cc1ccc(S(=O)(=O)O)c(-c2cccc3ccccc23)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.48
▸ MAOB P27338 1/20 0.48
▸ CA12 O43570 5/20 0.43
▸ CA1 P00915 5/20 0.43
▸ CA2 P00918 5/20 0.43
▸ CA9 Q16790 5/20 0.43
▸ SNCA P37840 1/20 0.43
▸ ELANE P08246 1/20 0.42
▸ MPL P40238 2/20 0.41
▸ CTRB1 P17538 1/20 0.40
▸ GPR84 Q9NQS5 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ CYP1A2 P05177 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6111642 0.86 ALDH1A1 (0.43) MAOAMAOBSNCAELANEKDM4E
SCHEMBL4360130 0.82 CA1 (0.50) CA12CA1CA2CA9SNCA
SCHEMBL3885120 0.81 ELANE (0.47) CA12CA1CA2CA9ELANE
SCHEMBL6109540 0.80 HSD11B1 (0.40) SNCAELANEMPLKDM4EALDH1A1
SCHEMBL7857421 0.80 ELANE (0.46) MAOAMAOBELANEMPLKDM4E
SCHEMBL6110174 0.79 SENP2 (0.42) MPLCTRB1GPR84KDM4EALDH1A1
SCHEMBL776844 0.79 SLC9A1 (0.39) SNCAELANEKDM4EALDH1A1LMNA
SCHEMBL15851425 0.79 TTR (0.56) CA12CA1CA2CA9SNCA
SCHEMBL25266704 0.78 ELANE (0.49) MAOAMAOBELANEMPLKDM4E
SCHEMBL8820520 0.78 PTGDR2 (0.47) MAOBCA12CA2CA9ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240158424-A1 METHOD FOR PRODUCING DIPHOSPHINE MONOXIDE TAKASAGO INTERNATIONAL CORPORATION (JP) 2024-05-16 — — US disclosed
EP-4361162-A2 METHOD FOR PRODUCING DIPHOSPHINE MONOXIDE Takasago International Corporation (JP) 2024-05-01 — — EP disclosed
EP-4310067-A1 METHOD FOR PRODUCING ORGANIC METAL NUCLEOPHILIC AGENT AND REACTION METHOD USING ORGANIC METAL NUCLEOPHILIC AGENT National University Corporation Hokkaido University (JP) 2024-01-24 — — EP disclosed
CN-117324042-A Catalytic system for deoxidizing phenolic derivative, and mild and efficient deoxidizing method and application thereof 中国科学院长春应用化学研究所 2024-01-02 — — CN disclosed
US-20230271988-A1 METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2023-08-31 — — US disclosed
WO-2022196796-A1 METHOD FOR PRODUCING ORGANIC METAL NUCLEOPHILIC AGENT AND REACTION METHOD USING ORGANIC METAL NUCLEOPHILIC AGENT 国立大学法人北海道大学 2022-09-22 — — WO disclosed
US-10463391-B2 Magnetic ferrocenyl-functionalized nanoparticle KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2019-11-05 — — US disclosed
US-10370397-B2 Phosphine substituted ferrocenyl complex Kind Fahd University of Petroleum and Minerals (SA) 2019-08-06 — — US disclosed
US-20190031697-A1 PHOSPHINE SUBSTITUTED FERROCENYL COMPLEX KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2019-01-31 — — US disclosed
US-20190029718-A1 MAGNETIC FERROCENYL-FUNCTIONALIZED NANOPARTICLE KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2019-01-31 — — US disclosed
US-20180099987-A1 FUNCTIONALIZED MAGNETIC NANOPARTICLE, A CATALYST, A METHOD FOR FORMING C-C BONDS KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2018-04-12 — — US disclosed
US-20180065117-A1 SOLID-SUPPORTED PALLADIUM(II) COMPLEX FOR CATALYZING MIZOROKI-HECK COUPLING REACTIONS AND A METHOD THEREOF KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2018-03-08 — — US disclosed
CN-103917522-B Process for producing N- (hetero) arylazoles 高砂香料工业株式会社 2016-06-15 — — CN disclosed
US-9233922-B2 Process for producing N-(hetero)arylazoles TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-01-12 — — US disclosed
EP-2736881-B1 PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES TAKASAGO PERFUMERY CO LTD (JP) 2015-10-07 — — EP disclosed
US-20140371461-A1 PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES TAKASAGO INTERNATIONAL CORPORATION (JP) 2014-12-18 — — US disclosed
CN-103917522-A Process for producing N- (hetero) arylazoles TAKASAGO PERFUMERY CO LTD 2014-07-09 — — CN disclosed
EP-2736881-A1 PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES Takasago International Corporation (JP) 2014-06-04 — — EP disclosed
WO-2013032035-A1 PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES TAKASAGO INTERNATIONAL CORPORATION (JP) 2013-03-07 — — WO disclosed
EP-0259007-A1 Process for producing azo pigment Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo (JP) 1988-03-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240158424-A1 METHOD FOR PRODUCING DIPHOSPHINE MONOXIDE TDO2, SCO2, DUOX1 MAOA 412/4885MAOB 301/4885CA12 609/4885
US-20180099987-A1 FUNCTIONALIZED MAGNETIC NANOPARTICLE, A CATALYST, A METHOD FOR FORMING C-C BONDS MSN, COIL, NSFL1C MAOA 1518/4885MAOB 1195/4885CA12 371/4885
US-20230271988-A1 METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE HPD, TALDO1, OGG1 MAOA 3053/4885MAOB 2987/4885CA12 2312/4885
US-20140371461-A1 PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES CYP3A4, HCN4, PPOX MAOA 1467/4885MAOB 2167/4885CA12 2762/4885
US-10370397-B2 Phosphine substituted ferrocenyl complex FECH, PHOSPHO1, FTH1 MAOA 2289/4885MAOB 2332/4885CA12 1446/4885
US-20190031697-A1 PHOSPHINE SUBSTITUTED FERROCENYL COMPLEX FECH, FOLR1, FOLR2 MAOA 680/4885MAOB 589/4885CA12 1256/4885
US-20180065117-A1 SOLID-SUPPORTED PALLADIUM(II) COMPLEX FOR CATALYZING MIZOROKI-HECK COUPLING REACTIONS AND A METHOD THEREOF DDT, PDK2, DNAJA2 MAOA 697/4885MAOB 814/4885CA12 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.